INFORMATION BY CANCER TYPE

Lymphoma

New Treatment Shows Promise in Lymphoma
BY Jason Harris
A type of CAR-T cell therapy is showing promise in a phase 1 study for patients with Hodgkin lymphoma and ALCL.
Fine, Not Fragile
BY Adriana Lecuona
Preventing Conflicts in Cancer Treatment Decisions
BY Theresa Sullivan Barger
To prevent family conflicts over cancer treatment decisions, experts recommend a series of frank conversations.
A New Drug for Mantle Cell Lymphoma On Its Way to Approval
BY Jason Harris
Acalabrutinib was granted a priority review to a new drug application (NDA) to be used to treat patients with mantle cell lymphoma (MCL) who have had previous treatment, according to AstraZeneca, the manufacturer of the drug.
 
Parent Age May Affect Child's Cancer Risk, Study Finds
BY Brielle Urciuoli
A recent study found that children of older parents may have an increased risk of certain types of cancers. 
Combination Is Promising in Follicular Lymphoma Treatment
BY Danielle Bucco
Keytruda (pembrolizumab) and Rituxan (rituximab) showed promising results for patients with follicular lymphoma in a recent study. 
Better Quality of Life Seen With Imbruvica for Lymphoma Population
BY Jason Harris
Patients with mantle cell lymphoma who were treated with Imbruvica had a better quality of life than those treated with another agent, according to the results of a recent study. 
New Trial Shows Promise in Treatment of Cutaneous T-Cell Lymphoma
BY Katie Kosko
A recent study could be practice-changing for the treatment of cutaneous T-cell lymphoma.
FDA Approves Tool for Blood Cancer Detection
BY Silas Inman
ClearLLab multicolor reagents (T1, T2, B1, B2, M) gained approval from the Food and Drug Administration (FDA) to detect chronic leukemia, acute leukemia, non-Hodgkin lymphoma, multiple myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN). This is the first approval the agency received for immunophenotyping on a flow cytometer.
 
Cancer Survivor Celebrates by Dancing with Scripps Doctor
BY Irene Hutchins, M.D., and her patient Steve Valentine,

Irene Hutchins, M.D., and her patient Steve Valentine, both accomplished ballroom dancers, made a pact to dance together once he had recovered from late-stage Burkitt lymphoma. They performed their victory dance June 11 during Cancer Survivors Day at Scripps Green Hospital, in La Jolla, California, where Hutchins treated Valentine.

Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Lymphoma CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Adult Hodgkin Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult Hodgkin lymphoma.
Adult Non-Hodgkin Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult non-Hodgkin lymphoma.
AIDS-Related Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of AIDS-Related Lymphoma.
Childhood Hodgkin Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of childhood Hodgkin lymphoma.
Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of childhood non-Hodgkin lymphoma.
Primary CNS Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of primary CNS lymphoma.
x